T1	p 25 43	prostatic cancer .
T2	p 162 216	previously untreated patients with prostatic cancer in
T3	p 623 674	patients with advanced disease no longer responsive
T4	i 238 317	dose Stilboestrol versus Cyproterone acetate versus Medroxyprogesterone acetate
T5	i 363 371	Estracyt
T6	i 473 485	Stilboestrol
T7	i 586 599	gynaecomastia
T8	i 723 751	Adriamycin or Procarbazine .
T9	o 752 776	Toxicity and early death